Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Chicago Students To Get Lessons On Diagnostic Testing From The "Unsung Heroes" Of The Clinical Lab Profession
Chicago high school students interested in science and health care will get a chance to learn about diagnostic tests and the laboratory professionals who perform them during the American Association for Clinical Chemistry"s 2009 Clinical Lab Expo on July 21 and 22.

Reengineering A Food Poisoning Microbe To Carry Medicines And Vaccines
Scientists have used genetic engineering to tame one of the most deadly food poisoning microbes and turn it into a potential new way of giving patients medicine and vaccines in pills rather than injections. The study is in the current issue of ACS" Molecular Pharmaceutics, a bi-monthly journal.
News of the day
Canada Continues To Work With National And International Partners To Manage The Spread Of The H1N1 Flu Virus
Health Minister Leona Aglukkaq updated Canadians on the H1NI flu virus response and reemphasized the Government of Canada"s ongoing collaboration with its national and international partners to manage the spread of this virus. The Minister and Canada"s Chief Public Health Officer, Dr. David Butler-Jones will be participating in an international meeting on the global response to H1N1 flu virus in Cancun, Mexico from July 1-3.
Endocrinology

Immunotherapy Against Tau Tangles In Alzheimer's Mouse Models

New insights into how a Phase III Alzheimer"s drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - at ICAD. Scientists also reported on how clinicians view and treat mild cognitive impairment (MCI), a research category used to define the state between normal ageing and Alzheimer"s, that is now being used widely in clinical practice. "Immunotherapy is an important and exciting avenue for dementia research. Unlike the previously reported development of an amyloid vaccine, this new preliminary research has produced antibodies that target the faulty tau protein. Introduction of these antibodies may prevent tangles from forming in nerve cells in the brain. Early results have shown some promise but this is preliminary research and some technical challenges need to be overcome before this study can be translated into drug treatments for people with dementia." Professor Clive Ballard Director of Research Alzheimer"s Society The International Conference on Alzheimer"s Disease is held in Vienna from 11 - 16 July. Please visit ICAD for further information. http://www.alzheimers.org.uk Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009